This observation supports the hypothesis that co-expression of isoleucine at position 539 and the F508del mutation presents a possible strategy to develop novel ‘humanized’ CF mouse models with more prominent lung disease, a topic that will be discussed in the section Humanized CFTR Animal Models of CF. This evidence concerns the gene CFTR and lung disorder.